Cilostazol Improves HFD-induced Hepatic Steatosis by Upregulating Hepatic STAMP2 Expression Through AMPK

Molecular Pharmacology - United States
doi 10.1124/mol.118.113217
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Ginsenoside Rg3 Ameliorated HFD-induced Hepatic Steatosis Through Downregulation of STAT5-PPARγ

Journal of Endocrinology
EndocrinologyMetabolismDiabetes
2017English

Miltefosine Suppresses Hepatic Steatosis by Activating AMPK Signal Pathway

PLoS ONE
Multidisciplinary
2016English

Paeoniflorin Ameliorates Fructose-Induced Insulin Resistance and Hepatic Steatosis by Activating LKB1/AMPK and AKT Pathways

Nutrients
NutritionFood ScienceDietetics
2018English

Modified SJH Alleviates FFAs-induced Hepatic Steatosis Through Leptin Signaling Pathways

Scientific Reports
Multidisciplinary
2017English

Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis Through Brown and Beige Adipose Tissue Function

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2016English

Rescue of MTP siRNA-induced Hepatic Steatosis by DGAT2 siRNA Silencing

Journal of Lipid Research
BiochemistryEndocrinologyCell Biology
2012English

Increased Expression of ATP-binding Cassette Transporter A1 by Cilostazol May Be a Possible Mechanism for Its Protective Effect Against Hepatic Steatosis

Endocrine Abstracts
2015English

AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice

Cell Metabolism
Cell BiologyMolecular BiologyPhysiology
2011English

Impaired Cardiolipin Biosynthesis Prevents Hepatic Steatosis and Diet-Induced Obesity

Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy